Syngene International's Q4 FY 2025-26 Quarterly Results

Result Summary

• Syngene International Ltd reported a 13.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 2.1%.
• Its expenses for the quarter were up by 2.8% QoQ and 7.6% YoY.
• The net profit increased 886.0% QoQ and decreased 19.3% YoY.
• The earnings per share (EPS) of Syngene International Ltd stood at 3.67 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Syngene International Ltd is a leading contract research organization (CRO) based in India, providing integrated services to global pharmaceutical, biotechnology, and agrochemical companies. The company specializes in discovery chemistry, biologics, and analytical services, among other offerings, enabling its clients to expedite research and development processes. Syngene operates in a dynamic industry where innovation and compliance with global standards are paramount. As of the latest updates, no major recent developments have been noted within the provided data, but the company continues to focus on expanding its capabilities and infrastructure to support a growing pipeline of client projects.

Revenue

In the fourth quarter of fiscal year 2026 (Q4FY26), Syngene International Ltd reported a total income of ₹1058.70 crores, representing a quarter-over-quarter (QoQ) increase of 13.5% compared to ₹932.50 crores in the third quarter of fiscal year 2026 (Q3FY26). Year-over-year (YoY), the total income increased by 2.1% from ₹1036.90 crores in the fourth quarter of fiscal year 2025 (Q4FY25). This growth in revenue is indicative of the company's ability to generate higher sales or service income relative to the previous periods, reflecting ongoing demand and potentially successful client engagements or project completions.

Profitability

Syngene International Ltd's profitability in Q4FY26 showed significant improvements when compared to Q3FY26, with the profit before tax rising to ₹196.00 crores from ₹28.40 crores, marking a 590.1% QoQ increase. However, there was a YoY decrease of 18.5% from ₹240.50 crores in Q4FY25. The tax expenses for Q4FY26 were ₹48.10 crores, up from ₹13.40 crores in Q3FY26, yet down 15.9% YoY from ₹57.20 crores in Q4FY25. Consequently, the profit after tax for Q4FY26 was ₹147.90 crores, which significantly increased by 886.0% QoQ from ₹15.00 crores in Q3FY26, but decreased by 19.3% YoY from ₹183.30 crores in Q4FY25. Earnings per share (EPS) followed a similar pattern, with Q4FY26 recording an EPS of ₹3.67, up 891.9% QoQ from ₹0.37 in Q3FY26, and down 19.5% YoY from ₹4.56 in Q4FY25.

Operating Metrics

Total expenses for Syngene International Ltd in Q4FY26 were ₹856.70 crores, reflecting a 2.8% QoQ increase from ₹833.50 crores in Q3FY26 and a 7.6% YoY increase from ₹796.40 crores in Q4FY25. The increase in expenses suggests ongoing operational or production-related costs that could be associated with scaling up or maintaining service delivery. The company's ability to manage these expenses relative to its income is crucial for sustaining profitability. The reported figures highlight the importance of expense management in the context of the company's overall financial health.